TSS:Rfhg 227824.1

Basic information about the TSS

---

TSS ID: rfhg_227824.1 Species: human Chr: chr22		Start: 20555026 End: 20555044 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC017110:-91 GeneID: 51586 HGNC/MGI_ID: HGNC:14248 UniProt_ID: Nearer transcript ids and distances:

Gene_name: MED15 Gene_symbol: MED15 Gene_synonyms: Arc105 CAG7A TIG-1 Gene_source: HGNC:14248

TATA-Box annotation

---

Distance to TSS:	46988
Nearest PromoterID:	NM_001293237
Entrez ID:	51586
Nearest Unigene:	Hs.517421
Nearest Refseq:	NM_015889
Nearest Ensembl:	ENSG00000099917
Gene Name:	MED15
Gene Alias:	ARC105|CAG7A|CTG7A|PCQAP|TIG-1|TIG1|TNRC7
Gene Type:	protein-coding
CpG%:	0.055556
GC%:	0.684211
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MED15 p2@MED15 p3@MED15 p4@MED15 p5@MED15 p6@MED15
Sample		p1@MED15	p2@MED15	p3@MED15	p4@MED15	p5@MED15	p6@MED15
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	61.95	1.56	0.39	0.00	0.00	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	60.09	2.83	0.61	0.00	0.00	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	58.26	3.28	0.58	0.39	0.00	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	47.82	1.87	0.42	0.62	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	46.79	1.57	0.22	0.45	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	46.71	2.13	0.39	0.39	0.00	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	61.23	3.27	0.87	0.65	0.00	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	58.86	3.63	0.24	0.48	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	63.05	2.56	0.85	0.43	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	82.31	5.22	1.16	0.00	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	93.38	6.87	2.43	1.21	0.00	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	83.34	6.50	0.00	1.22	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	34.01	5.00	4.51	0.64	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	30.52	5.71	4.96	0.90	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	32.05	3.73	3.51	0.88	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	30.93	6.04	1.76	1.51	0.00	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	25.55	4.80	1.75	1.53	0.00	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	25.73	2.11	2.53	1.69	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	22.39	3.73	3.73	1.60	0.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	28.28	9.63	3.61	2.26	0.00	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	31.54	7.22	2.14	2.14	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	28.14	8.11	1.90	3.97	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	32.18	7.76	2.46	1.94	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	28.88	8.49	3.15	2.43	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	23.22	7.74	2.58	2.58	0.00	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	20.89	8.23	1.58	3.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.02	5.49	1.65	4.95	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	30.88	8.02	3.54	4.24	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	25.68	6.78	1.94	3.07	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	28.05	4.34	1.63	3.08	0.00	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	31.40	4.40	1.26	1.47	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.40	5.08	0.98	3.13	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	32.08	6.54	1.06	2.53	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	29.85	6.76	2.31	6.27	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.61	4.67	2.24	3.37	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	27.59	5.75	1.92	1.92	0.00	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	28.20	4.70	1.02	3.27	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	31.63	6.65	1.81	3.83	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	28.90	7.02	0.54	3.78	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	30.49	4.56	1.20	3.60	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	27.53	3.76	1.41	2.35	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	30.01	5.56	1.61	3.66	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	29.95	4.22	0.84	6.12	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	31.29	4.02	1.57	3.32	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	32.73	6.42	2.21	3.41	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	32.11	5.58	0.93	3.02	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	32.15	3.60	2.40	2.40	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	28.31	5.07	1.19	4.77	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	36.15	6.22	0.24	3.11	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	35.59	7.48	1.42	3.44	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	44.88	5.74	1.23	3.48	0.00	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	45.81	5.78	1.11	1.56	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	27.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	35.13	9.23	0.35	2.13	0.00	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	35.46	5.30	1.66	2.32	0.00	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	36.07	8.39	0.84	27.68	0.00	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	38.12	7.81	0.92	9.64	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	29.49	6.81	0.97	1.62	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	20.55	3.85	0.32	0.64	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	36.46	4.71	0.31	4.40	0.00	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.14	4.94	1.41	4.23	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	21.87	2.24	0.56	4.49	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	46.97	11.15	0.00	11.94	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	36.69	6.80	0.34	4.42	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	25.02	5.52	1.62	0.32	0.00	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	26.27	4.26	0.71	1.42	0.00	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00	48.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	0.00	0.00	78.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	25.35	2.44	0.00	1.95	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	34.22	5.95	1.98	0.50	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	31.90	4.22	0.47	2.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	23.51	6.95	0.00	5.30	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.80	5.26	0.31	1.55	0.00	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	21.40	3.97	0.31	3.06	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	39.28	1.11	0.32	1.74	0.00	0.63
Adipocyte - breast, donor2	11327-117E4	44.60	0.80	0.64	0.96	0.00	0.96
Adipocyte - omental, donor1	11473-119C6	45.55	0.64	0.64	2.42	0.89	1.02
Adipocyte - omental, donor2	11474-119C7	30.65	1.49	0.75	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	20.10	1.67	2.34	0.67	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	20.42	1.91	0.64	1.28	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	18.69	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	36.13	0.90	0.00	4.97	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	42.05	0.52	1.04	0.17	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	59.26	3.52	1.96	0.39	0.39	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	32.69	2.32	1.03	0.77	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	38.19	1.95	0.84	0.84	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	35.86	2.35	1.18	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	51.08	1.77	0.97	0.24	0.24	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	38.09	2.58	0.97	0.00	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	28.26	0.00	0.00	0.00	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	32.27	2.23	1.67	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	28.70	2.08	2.08	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	30.89	1.76	1.26	0.00	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	27.49	1.64	0.98	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	24.66	0.91	0.00	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	67.40	0.66	0.44	6.41	0.00	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	91.44	0.72	1.43	6.10	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	49.12	0.00	2.40	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	95.89	0.72	0.54	5.40	0.18	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	73.63	3.35	0.00	3.35	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	90.81	1.03	0.21	6.37	0.41	0.82
Anulus Pulposus Cell, donor1	11248-116E6	33.07	0.57	0.80	0.69	0.00	0.57
Anulus Pulposus Cell, donor2	11463-119B5	25.23	0.49	0.49	0.24	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	26.96	0.90	0.00	0.90	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	32.13	0.87	0.43	1.74	0.00	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	28.10	1.20	0.00	0.90	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	26.56	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	21.12	0.66	0.00	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	25.99	0.32	0.65	0.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	26.21	0.49	0.49	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	21.97	0.59	0.59	1.19	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	23.35	1.51	0.00	0.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.06	1.45	0.00	1.45	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	22.57	0.00	0.00	1.25	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	24.05	0.66	0.49	2.97	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	31.39	2.73	0.00	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	15.23	0.00	0.00	1.21	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	27.33	0.00	1.07	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.97	0.19	0.57	1.13	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	25.39	0.53	0.27	0.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	17.56	1.95	0.00	0.98	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	21.89	0.66	0.33	1.33	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	1.20	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	28.82	0.86	0.34	0.69	0.00	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	27.18	0.49	0.00	2.43	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	27.32	0.00	0.00	1.52	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	26.65	0.00	0.00	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	27.93	0.57	0.57	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	21.81	0.86	0.43	1.50	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	17.55	0.77	0.52	0.77	0.00	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	21.11	0.00	1.41	0.47	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	28.62	0.32	0.00	1.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	24.97	0.71	0.71	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	21.06	0.58	0.58	1.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	25.29	1.20	0.60	1.51	0.30	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	0.00	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	28.99	1.02	0.00	2.54	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.65	1.27	0.76	1.53	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.87	0.86	0.86	1.73	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	22.65	0.42	0.42	1.69	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	20.30	0.58	0.00	0.87	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	18.89	0.94	0.00	1.89	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	20.34	0.85	1.02	1.70	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	0.00	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	2.11	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	21.87	0.43	0.21	2.14	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	16.24	0.60	0.00	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	26.24	0.73	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	24.37	1.84	0.92	1.61	0.00	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	2.55	0.00	2.55	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	14.49	0.00	0.00	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	30.55	0.83	0.21	1.65	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	18.36	0.61	0.31	0.31	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	29.16	1.43	0.48	1.91	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	28.83	0.22	0.44	1.77	0.00	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	0.00	0.00	4.58	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	19.39	0.55	1.66	1.66	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	25.95	0.26	0.26	0.79	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	15.26	0.73	0.36	1.45	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	83.39	1.11	0.98	1.23	0.00	0.37
Astrocyte - cerebellum, donor2	11580-120F5	65.21	0.34	0.86	1.37	0.00	0.86
Astrocyte - cerebellum, donor3	11661-122F5	46.56	0.84	0.63	0.63	0.00	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	51.24	0.35	1.05	1.39	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	56.94	1.94	1.78	3.72	0.00	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	65.18	2.24	1.49	2.24	0.00	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	109.64	1.49	0.34	0.11	0.00	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	98.35	1.00	0.13	0.25	0.00	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	93.09	0.57	0.11	0.00	0.00	0.46
Basophils, donor1	12241-129G9	72.44	1.83	0.78	2.09	2.88	0.26
Basophils, donor2	12242-129H1	109.32	2.16	0.36	2.16	18.76	0.72
Basophils, donor3	12243-129H2	101.72	2.06	1.32	0.15	1.18	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	69.21	1.08	0.43	3.67	0.00	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	98.75	1.83	0.00	10.06	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	52.10	0.63	0.00	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	79.02	1.04	1.04	1.87	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	55.73	2.76	1.38	2.30	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	34.91	1.44	0.54	3.24	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	39.47	0.72	0.62	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	53.10	0.00	0.23	0.00	0.00	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	36.45	0.96	1.60	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	151.60	2.25	1.13	13.53	3.38	0.00
CD14+ Monocytes, donor2	11305-117B9	154.98	4.08	0.74	20.42	11.32	1.86
CD14+ Monocytes, donor3	11381-118B4	134.80	2.41	0.66	11.85	4.17	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	55.19	4.81	2.26	0.00	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	64.06	6.82	2.27	0.00	2.65	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	59.83	9.20	4.60	0.33	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	101.18	1.01	2.46	1.73	0.72	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	75.44	2.41	1.21	2.11	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	104.23	1.90	1.66	2.61	0.00	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	77.67	3.35	1.34	2.68	0.33	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	75.63	2.21	0.55	2.48	0.00	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	86.28	3.22	1.98	3.47	0.25	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	70.29	2.74	0.39	5.09	0.00	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	69.97	1.96	0.89	3.56	0.89	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	68.99	2.39	0.87	3.26	0.00	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	76.09	3.51	1.17	11.24	0.70	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	106.66	3.70	2.64	7.92	0.53	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	97.62	3.33	1.11	7.77	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	79.88	1.49	2.08	3.12	0.59	1.19
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	80.82	2.39	1.20	2.59	0.20	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	68.91	2.29	1.04	2.91	0.21	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	85.57	2.97	0.46	23.34	0.23	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	74.42	2.49	0.68	13.12	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	88.60	1.31	0.44	17.46	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	69.67	1.34	0.81	0.54	0.27	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	87.23	1.22	0.87	2.09	0.00	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	101.42	1.26	0.42	1.26	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	96.08	4.41	0.73	19.11	0.18	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	120.12	4.23	0.70	20.08	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	157.50	4.39	0.44	14.92	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	73.76	2.44	0.87	3.31	0.17	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	79.91	4.83	0.00	4.46	0.37	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	83.42	2.59	0.86	3.88	0.00	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	91.73	2.05	0.82	13.10	1.64	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	89.47	4.64	0.23	14.84	0.00	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	84.68	3.25	0.23	12.06	0.00	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	41.20	1.53	0.00	0.00	0.00	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	58.67	2.08	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	35.52	2.17	0.22	0.00	0.00	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	92.34	2.65	1.40	0.16	0.00	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	64.62	2.79	0.87	0.17	0.00	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	102.34	5.35	2.01	0.00	0.00	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	54.35	0.77	1.02	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	49.62	0.22	1.10	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	44.43	0.42	0.63	0.00	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	34.55	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	47.46	0.68	0.00	0.00	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	42.46	2.07	2.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	49.57	1.07	0.00	0.00	1.07	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	43.42	1.61	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	55.45	0.70	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	50.98	3.14	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	42.19	0.00	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	92.87	3.29	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	95.76	1.45	0.73	0.73	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	80.27	1.51	0.50	0.50	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	46.87	2.02	2.83	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	36.75	0.00	0.80	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	48.19	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	98.32	1.69	1.12	5.62	2.81	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	49.60	1.88	0.75	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	38.56	0.90	0.90	0.23	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	172.82	4.28	4.28	0.36	29.99	11.78
CD4+ T Cells, donor2	11306-117C1	140.84	5.51	1.22	3.67	58.17	13.47
CD4+ T Cells, donor3	11382-118B5	143.65	4.27	1.52	0.91	39.65	9.76
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	82.95	4.59	3.57	0.00	34.97	13.78
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	81.98	4.04	0.67	0.00	31.89	11.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	75.31	4.02	1.72	0.00	42.83	14.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	106.20	4.27	5.69	0.47	57.84	16.12
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	103.24	7.02	7.73	0.00	57.59	13.34
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	85.70	0.00	3.30	0.00	52.74	16.48
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	69.80	2.75	1.01	0.00	21.97	9.25
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	69.14	3.39	0.68	0.17	18.30	7.63
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	53.84	1.45	0.81	0.16	17.57	9.51
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	78.45	2.69	1.34	0.00	66.80	10.31
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	78.61	2.10	1.05	0.35	45.77	11.53
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	97.24	6.16	1.76	0.44	69.96	11.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	103.72	6.32	0.84	0.00	5.48	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	68.98	2.70	1.25	0.00	2.29	2.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	50.45	2.34	0.00	0.00	2.00	2.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	106.05	4.89	4.08	0.54	12.51	7.34
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	115.77	6.43	6.97	0.00	9.65	8.04
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	107.59	7.17	1.79	0.00	1.79	7.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	109.03	2.41	1.48	0.56	16.50	5.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	85.35	2.60	1.08	0.00	9.53	3.25
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	88.68	3.36	1.89	0.00	7.78	2.52
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	82.92	1.52	3.54	2.02	27.30	4.55
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	66.72	3.03	3.03	0.00	20.36	7.37
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	93.26	3.49	2.61	0.00	22.23	10.02
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	97.49	2.47	5.94	0.00	31.18	10.89
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	88.63	2.77	0.92	0.00	37.85	12.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	73.98	5.58	2.79	0.00	30.71	15.35
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	120.46	3.60	4.71	0.00	14.95	9.42
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	123.43	5.64	5.40	0.00	23.56	12.02
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	92.40	6.16	6.16	0.00	53.90	10.78
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	98.84	6.45	3.58	0.00	36.17	5.73
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	81.71	1.38	2.77	0.00	30.47	8.31
CD8+ T Cells, donor1	11226-116C2	149.62	7.53	1.31	9.49	63.51	10.48
CD8+ T Cells, donor2	11307-117C2	132.53	4.88	0.38	11.64	89.35	7.13
CD8+ T Cells, donor3	11383-118B6	157.30	4.04	2.02	5.55	68.17	7.32
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	33.26	0.46	0.00	0.00	0.23	4.13
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	23.48	0.96	0.00	0.00	0.24	2.88
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	21.89	0.55	0.00	0.00	0.27	3.01
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	25.22	2.40	0.30	0.00	0.60	4.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	36.48	2.64	0.24	0.00	0.24	2.64
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	31.61	1.59	0.23	0.23	0.23	3.64
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	32.81	1.96	0.00	0.00	0.00	1.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	28.95	0.79	0.00	0.26	0.26	2.11
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	31.19	1.88	0.00	0.00	0.94	3.52
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	30.19	0.60	0.00	0.30	0.30	3.32
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	30.79	2.61	0.00	0.29	0.29	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	30.37	2.40	0.00	0.00	0.53	2.93
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	37.21	3.06	0.00	0.88	0.44	6.57
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	46.45	5.01	0.00	0.46	0.91	2.73
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	28.34	7.46	0.00	1.49	0.00	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	31.69	1.44	0.00	0.36	0.00	2.52
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	35.10	1.73	0.00	0.29	0.86	3.74
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	33.70	1.41	0.00	0.24	0.47	1.89
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	41.51	2.85	0.00	0.00	0.95	2.22
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	38.14	1.54	0.00	1.23	0.00	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	38.47	1.60	0.00	0.00	0.00	1.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	32.13	1.53	0.00	0.76	0.38	3.06
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	34.68	2.36	0.00	0.39	0.00	3.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	27.99	2.27	0.00	0.00	0.76	3.78
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	53.00	8.83	0.00	0.00	0.80	12.85
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	48.96	6.99	0.00	0.70	3.50	16.79
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	62.11	6.01	0.00	0.00	1.00	5.01
Cardiac Myocyte, donor1	11525-119I4	34.73	0.00	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	22.23	0.49	0.00	0.00	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	25.99	0.32	0.11	0.42	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	30.85	1.39	0.35	3.12	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	43.71	1.07	0.71	2.13	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	37.77	1.25	0.68	2.39	0.11	0.68
Chondrocyte - re diff, donor2	11339-117F7	106.54	2.69	1.79	7.16	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	62.68	1.21	2.02	6.87	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	50.49	1.95	0.69	1.72	0.00	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	43.18	1.71	0.00	1.92	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	56.37	1.06	0.62	1.42	0.18	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	88.58	4.31	5.23	0.83	1.56	0.92
Corneal Epithelial Cells, donor1	11526-119I5	84.97	1.76	0.44	3.51	0.22	1.10
Corneal Epithelial Cells, donor2	11606-120I4	48.92	1.14	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	59.31	0.77	0.51	1.28	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	37.48	0.00	0.00	0.33	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	42.58	0.00	0.00	0.00	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	49.57	0.32	0.00	0.32	0.11	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	96.00	1.02	1.71	0.34	0.34	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	90.10	1.96	0.00	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	118.08	0.48	0.97	0.97	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	87.22	0.50	0.67	1.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	57.50	0.59	0.59	0.00	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	71.26	0.57	0.85	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	57.01	0.79	1.57	1.97	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	55.56	1.45	0.58	1.16	0.00	0.87
Endothelial Cells - Artery, donor2	11341-117F9	74.11	0.47	0.94	0.47	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	94.84	0.35	1.05	1.75	0.00	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	60.73	0.89	0.89	0.00	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	70.29	0.91	0.91	0.30	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	80.34	1.41	0.00	0.00	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	67.75	2.67	0.59	0.59	0.00	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	61.44	0.52	0.00	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	68.06	1.13	0.57	0.00	0.00	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	72.82	1.20	2.00	1.20	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	52.41	0.00	0.52	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	86.10	1.74	0.99	0.25	0.00	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	56.92	1.52	1.74	0.43	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	77.31	2.20	1.83	0.24	0.00	0.24
Endothelial Cells - Vein, donor1	11267-116G7	59.15	0.00	0.00	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	106.17	0.00	0.70	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	59.66	1.26	0.31	0.16	0.00	0.16
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	30.49	0.00
Eosinophils, donor2	12245-129H4	160.08	16.50	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	99.87	17.83	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	60.35	1.22	0.49	3.42	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	62.40	0.00	0.00	4.16	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	0.00	0.00	0.00	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	32.43	0.41	0.41	3.69	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.04	0.88	0.66	0.44	0.11	0.66
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	16.68	0.87	0.65	0.22	0.00	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	44.51	0.24	0.12	1.58	0.12	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	78.74	5.73	3.28	4.23	1.09	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	39.13	1.37	0.63	0.95	0.32	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	45.06	3.69	2.90	1.05	0.26	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	43.85	1.00	0.00	2.33	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	28.58	0.00	0.00	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	61.39	0.00	0.00	2.27	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	41.48	0.32	0.32	1.89	0.00	0.63
Fibroblast - Cardiac, donor4	11452-119A3	67.29	1.21	0.91	0.91	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	43.15	0.51	1.14	0.51	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	43.05	0.61	1.06	0.45	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	74.77	1.61	1.21	0.40	0.00	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	35.81	0.43	0.86	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	42.48	1.46	0.00	2.93	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	91.33	1.38	0.69	0.69	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	39.86	3.22	0.68	0.00	0.17	0.68
Fibroblast - Dermal, donor1	11269-116G9	26.06	0.47	0.00	0.47	0.00	0.47
Fibroblast - Dermal, donor2	11346-117G5	50.00	0.94	0.47	1.89	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	29.13	0.24	0.12	0.85	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	42.62	0.79	0.68	1.70	0.00	0.34
Fibroblast - Dermal, donor5	11454-119A5	41.87	1.22	0.70	1.40	0.00	0.35
Fibroblast - Dermal, donor6	11458-119A9	50.03	0.81	0.65	2.44	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	55.18	1.04	0.62	1.04	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	67.60	2.62	1.05	1.31	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	55.61	1.19	0.13	2.24	0.00	0.26
Fibroblast - Gingival, donor3	11394-118C8	66.91	2.13	1.74	0.58	0.10	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	33.24	0.00	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	35.24	1.23	0.88	0.70	0.00	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	67.19	1.40	0.47	1.87	0.00	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	50.98	1.08	0.68	2.03	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	94.22	2.82	1.06	4.94	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	45.34	1.02	0.58	1.46	0.00	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	53.04	0.68	0.82	1.36	0.27	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	53.42	0.33	0.33	2.19	0.00	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	50.62	1.61	1.32	0.88	0.00	0.29
Fibroblast - Lung, donor1	11270-116H1	46.22	0.00	1.36	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	31.34	1.49	0.00	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	40.73	0.42	0.21	2.32	0.00	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	179.93	0.83	0.00	2.50	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	61.54	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	54.02	0.56	0.00	1.96	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	162.79	0.41	0.81	6.09	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	95.86	0.00	0.00	7.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	83.39	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	45.20	0.78	0.19	1.16	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	69.32	1.67	1.06	2.12	0.00	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	106.79	1.22	0.92	4.28	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	51.52	0.76	1.14	1.14	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	35.37	0.81	0.00	0.81	0.00	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	35.14	1.74	1.04	0.93	0.00	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	31.17	0.44	0.44	1.11	0.00	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	144.67	2.84	0.41	5.28	0.61	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	57.47	0.67	0.67	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	20.95	0.79	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	102.40	1.79	0.79	2.98	0.00	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	45.29	0.89	1.07	3.91	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	52.62	1.18	0.79	5.32	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	76.42	1.81	0.60	2.71	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	60.88	1.62	1.08	3.67	0.00	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	73.90	2.53	2.02	2.02	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	53.00	0.49	0.82	2.46	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	129.13	1.80	2.01	4.81	0.60	0.40
Fibroblast - skin normal, donor2	11561-120D4	60.68	1.00	0.50	3.62	0.10	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	110.01	3.63	2.72	4.23	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	55.76	1.82	1.08	2.82	0.00	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	49.23	1.71	1.20	0.68	0.34	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	72.91	0.99	2.30	4.27	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	61.89	0.53	0.53	7.67	0.00	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	57.01	0.34	0.34	4.89	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	16.00	0.31	0.31	2.51	0.00	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	49.68	2.61	0.00	0.00	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	57.38	1.04	0.52	6.76	0.00	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	73.39	1.04	0.52	6.51	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	67.97	1.79	1.28	4.34	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	23.73	0.00	0.77	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	19.78	0.64	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	19.97	0.57	1.71	0.00	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	33.09	10.20	8.82	0.00	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	32.42	9.36	5.71	0.00	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	24.96	2.38	4.56	0.00	0.00	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	26.70	5.82	5.29	0.00	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	40.44	7.18	6.52	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	19.90	0.88	1.33	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	34.48	1.84	2.69	0.00	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	36.94	3.45	2.34	0.12	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	30.62	1.88	1.61	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	53.03	1.73	1.36	0.99	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	52.46	1.25	0.83	1.52	0.00	1.52
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	43.30	1.42	0.61	1.02	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	53.62	5.02	1.83	0.46	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	51.20	1.74	1.12	0.87	0.00	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	66.67	1.31	1.31	0.44	0.00	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	42.84	3.25	0.89	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	44.51	2.70	3.50	0.16	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	44.46	0.45	3.35	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	53.63	2.22	4.03	0.00	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	38.34	2.37	3.73	0.17	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	63.93	2.04	1.77	0.53	0.09	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	138.81	3.23	3.54	0.21	0.00	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	128.42	3.07	1.54	0.34	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	57.65	1.66	3.32	0.33	0.11	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	61.48	2.75	1.91	0.42	0.00	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	51.05	3.27	2.86	0.61	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	54.67	3.30	3.51	0.00	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	49.11	2.42	3.80	0.12	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	61.04	4.17	3.00	0.33	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	60.40	0.66	3.31	0.00	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	63.34	3.32	3.94	0.37	0.00	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	60.46	3.40	2.27	0.81	0.00	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	65.11	3.53	1.60	0.00	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	57.89	1.99	2.46	0.47	0.00	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	68.96	2.37	1.74	0.32	0.00	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	64.47	2.43	2.13	0.30	0.00	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	50.70	1.67	3.14	0.84	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	71.79	3.73	3.07	1.76	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	62.56	2.81	3.09	0.00	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	66.85	1.39	1.20	0.83	0.00	0.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	71.66	1.07	1.34	0.80	0.00	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	73.60	1.99	1.38	1.07	0.00	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	58.81	1.81	1.42	0.52	0.13	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	83.49	2.71	1.36	0.54	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	69.50	1.47	1.29	0.55	0.00	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	66.01	1.10	1.10	0.22	0.00	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	210.25	11.90	4.96	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	51.45	1.32	1.06	0.92	0.00	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	50.24	1.21	0.20	1.01	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	298.38	7.62	8.13	4.83	1.27	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	43.20	1.59	1.79	0.20	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	35.90	1.69	3.08	0.00	0.00	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	34.17	0.82	3.68	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	18.78	0.00	1.56	0.00	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	19.50	0.57	1.13	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	25.83	0.92	1.84	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	17.32	0.00	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	28.24	1.16	1.16	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	22.46	1.60	1.60	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	26.08	1.74	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	24.41	0.33	1.63	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	28.83	4.12	3.71	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	53.32	3.33	10.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	23.49	1.12	1.96	0.00	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	28.44	1.63	0.65	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	27.68	1.68	4.19	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	30.53	3.18	4.13	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	21.74	1.36	2.72	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	25.06	6.26	2.09	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	35.51	2.86	2.29	0.00	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	20.42	1.18	2.37	0.00	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	0.00	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	27.34	2.07	1.24	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	29.23	2.07	2.99	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	21.53	1.92	3.46	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	23.14	2.61	2.28	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	19.40	2.01	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	28.90	2.70	1.16	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	36.97	2.05	1.37	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	0.00	7.45	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	30.67	3.30	3.77	0.00	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	24.14	1.21	4.22	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	26.96	2.03	1.53	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	32.31	3.59	3.19	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	30.59	1.48	4.44	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	36.59	3.54	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	30.34	1.75	4.08	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	28.53	3.51	3.07	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	21.19	0.85	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	33.43	2.98	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	26.20	1.94	1.46	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	57.07	1.14	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	46.99	0.83	1.25	0.42	0.00	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	68.59	1.12	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	40.60	1.27	0.32	2.85	0.32	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	23.81	0.42	0.00	0.84	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	25.53	1.86	0.81	0.23	0.00	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	24.48	2.53	0.34	0.34	0.00	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	26.16	2.50	0.68	1.14	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	28.64	1.53	1.09	0.66	0.00	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.72	0.86	0.00	0.64	0.00	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	23.25	0.86	1.08	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	23.16	1.62	0.37	0.25	0.00	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	23.16	2.23	0.51	0.51	0.00	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	23.71	2.56	0.32	0.32	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	78.35	0.56	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	80.50	0.87	1.30	0.87	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	75.84	1.06	0.71	1.06	0.00	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	56.67	1.45	2.18	0.73	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	30.25	0.17	0.00	1.22	0.00	0.70
Hepatocyte, donor1	11523-119I2	30.27	3.63	2.42	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	16.16	3.23	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	34.97	1.84	1.23	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	69.84	1.31	3.26	0.00	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	58.90	3.50	1.75	1.05	0.00	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	43.49	0.41	0.69	1.92	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	273.81	15.92	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	267.01	20.03	0.00	6.68	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	352.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	242.27	0.00	0.00	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	280.30	2.50	7.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	142.42	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	261.42	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	260.53	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	305.37	3.25	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	255.10	1.67	0.00	1.67	0.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	265.03	3.63	3.63	0.00	0.00	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	287.19	5.29	3.97	0.00	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	190.69	3.33	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	272.39	0.00	0.00	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	171.32	2.52	3.15	0.00	0.00	3.15
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	247.46	6.19	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	160.98	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	250.02	1.29	0.00	0.00	0.00	3.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	334.86	1.61	1.61	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	346.50	11.95	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	280.32	2.44	0.00	0.00	0.00	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	321.99	2.52	1.26	0.00	0.00	2.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	186.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	260.39	2.41	1.61	0.00	0.00	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	215.12	2.77	0.00	0.00	0.00	3.69
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	226.21	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	158.13	2.36	0.00	0.00	0.00	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	173.23	1.81	2.72	0.00	0.00	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	162.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	203.39	3.23	3.23	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	278.23	5.08	0.00	0.00	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	213.59	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	232.12	3.83	2.55	0.64	0.00	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	231.48	5.47	1.82	0.00	0.00	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	205.46	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	250.64	3.57	2.14	0.71	0.00	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	245.56	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	271.03	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	142.29	2.47	0.31	0.00	0.00	1.54
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	251.11	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	204.30	3.14	6.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	191.93	4.87	1.39	0.00	0.00	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	365.16	0.00	8.85	0.00	0.00	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	188.04	6.48	3.24	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	258.96	3.49	2.62	1.74	0.00	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	276.72	6.75	6.75	0.00	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	376.33	3.48	0.00	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	234.69	2.13	4.27	0.00	0.00	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	282.63	5.54	0.00	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	199.47	5.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	198.81	10.12	2.76	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	366.06	0.00	12.10	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	415.98	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	281.26	4.23	9.52	1.06	0.00	5.29
Keratinocyte - epidermal, donor1	11272-116H3	67.07	1.06	0.16	2.53	0.00	0.73
Keratinocyte - epidermal, donor2	11349-117G8	62.08	1.76	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	66.92	1.23	0.76	1.80	0.00	0.19
Keratinocyte - oral, donor1	11251-116E9	96.94	1.93	0.45	8.85	0.00	1.59
Keratocytes, donor1	11527-119I6	70.49	3.78	3.44	2.06	0.00	0.00
Keratocytes, donor2	11607-120I5	52.73	0.00	0.00	1.17	0.00	1.17
Keratocytes, donor3	11688-122I5	26.87	0.79	1.38	0.00	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	57.15	10.99	26.37	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	42.07	2.16	0.00	2.16	0.00	3.24
Lens Epithelial Cells, donor2	11609-120I7	46.48	2.42	1.85	1.27	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	38.85	0.91	0.71	1.31	0.00	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	67.00	1.54	0.12	0.24	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	39.91	1.12	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	58.40	0.79	0.16	0.16	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	40.87	0.54	0.00	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	47.91	0.63	0.32	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	42.80	0.97	0.32	0.22	0.00	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	52.12	0.82	0.00	0.00	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	44.50	1.26	0.25	0.00	0.00	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	57.00	1.41	0.56	0.56	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	42.32	0.40	0.40	0.40	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	44.79	0.97	0.39	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	43.88	1.48	0.74	0.37	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	44.95	1.39	0.70	0.35	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	42.46	1.67	0.24	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	45.05	1.10	0.14	0.41	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	46.19	1.23	0.62	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	37.72	1.25	0.31	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	57.46	1.83	0.73	0.37	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	52.99	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	52.72	0.88	0.00	0.00	0.00	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	53.27	0.50	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	52.86	0.97	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	44.70	1.62	0.54	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	49.50	0.91	0.45	0.45	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	40.95	0.52	1.04	0.00	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	41.67	0.84	0.63	0.00	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	45.11	1.50	0.30	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	37.15	2.06	0.69	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	44.59	1.69	0.75	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	41.14	0.74	0.42	0.11	0.00	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	45.55	0.97	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	34.07	1.98	0.00	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	51.04	1.24	0.50	0.12	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	51.09	1.85	0.00	0.74	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	38.05	1.24	0.25	0.00	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	46.06	1.24	0.41	0.55	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	49.21	2.57	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	52.04	1.52	0.61	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	42.69	0.98	0.42	0.14	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	45.16	2.13	0.36	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	39.75	0.00	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	48.08	1.09	0.47	0.47	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	35.45	1.07	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	52.59	0.98	0.00	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	47.32	1.41	0.47	0.47	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	68.68	1.24	0.62	0.62	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	39.19	1.28	0.51	0.51	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	44.46	1.79	0.30	0.30	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	32.22	6.90	0.00	0.77	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	20.78	3.71	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	30.89	5.92	0.85	1.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	35.87	1.41	0.00	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	27.09	5.60	1.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.73	3.09	0.52	0.00	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	22.60	3.57	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	30.31	4.98	2.04	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	20.94	4.36	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	24.31	3.15	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	48.77	4.88	1.63	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	30.81	7.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	28.93	3.88	2.47	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	19.32	4.66	2.00	0.67	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	38.20	4.08	1.02	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	24.28	2.93	0.80	0.53	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	30.61	3.40	1.51	0.19	0.00	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	27.00	4.91	1.23	1.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	35.88	6.52	1.63	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	27.90	2.71	0.62	0.00	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	25.78	3.92	0.56	0.28	0.00	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	42.24	4.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	34.84	2.90	0.87	0.29	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	25.71	2.39	0.90	0.30	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	42.60	3.32	1.66	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	41.71	6.01	1.41	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	32.82	4.06	2.21	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	27.63	3.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	36.07	3.07	1.54	0.38	0.00	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	29.44	1.70	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	24.61	2.46	1.64	0.00	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	44.74	4.52	0.90	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	28.73	2.15	2.15	0.72	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	25.39	4.48	0.00	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	41.99	4.09	1.11	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	21.11	2.15	0.86	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	37.68	5.99	0.00	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	49.31	4.33	0.67	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	34.39	6.03	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	39.82	4.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	39.18	2.06	1.72	0.69	0.00	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	37.57	4.83	0.00	0.00	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	47.81	3.37	1.35	0.00	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	42.60	2.59	1.48	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	23.26	5.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	28.56	5.29	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	41.62	4.80	1.20	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	34.89	4.36	0.73	0.73	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	42.16	3.83	2.30	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	38.48	6.41	1.48	0.00	0.00	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	0.94	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	38.72	8.05	2.51	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	44.61	4.51	1.35	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	34.42	6.88	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	41.86	6.68	0.89	1.78	0.00	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	48.49	4.30	1.56	0.39	0.00	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	29.69	2.64	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	47.22	9.34	1.56	1.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	42.01	5.69	2.19	1.75	0.00	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	29.63	4.47	0.00	0.56	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	43.72	8.39	1.32	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	44.74	3.47	1.54	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	37.47	4.05	1.01	1.52	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	39.41	2.88	0.96	3.36	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	40.55	5.57	1.19	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	26.13	3.65	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	26.98	5.53	1.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	39.14	4.56	2.28	0.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	38.73	6.71	1.03	1.55	0.00	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	41.72	6.05	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	43.10	6.34	1.58	0.32	0.00	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	33.05	7.46	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	27.58	4.60	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	52.97	3.09	1.03	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	31.12	9.20	0.71	0.71	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	36.32	3.97	1.70	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	44.93	3.74	0.83	1.66	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	42.28	7.83	1.57	2.35	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	31.32	5.43	1.25	1.25	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	44.61	3.72	1.39	0.00	0.00	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	26.76	5.35	0.00	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	41.17	2.67	2.14	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	48.90	2.02	1.62	1.62	0.00	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	26.62	4.59	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	28.45	4.45	0.00	0.00	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	64.40	7.98	1.71	0.57	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	37.58	5.37	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	34.47	3.83	0.00	0.55	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	42.76	8.91	0.45	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	50.69	4.94	0.52	0.52	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	42.44	6.63	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	76.91	8.31	2.08	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	44.44	3.42	1.14	0.23	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	40.37	1.47	0.18	0.92	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	46.01	4.33	1.18	0.39	0.00	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	26.55	0.53	1.06	2.12	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	46.11	0.79	0.48	10.93	0.00	0.95
Mallassez-derived cells, donor3	11930-125I4	44.89	1.67	0.69	5.56	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	71.34	1.20	0.40	5.58	0.00	0.20
Mammary Epithelial Cell, donor2	11350-117G9	62.83	0.87	0.00	2.90	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	95.03	1.00	0.25	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	156.60	2.71	0.00	2.03	4.07	2.71
Mast cell, donor1	11563-120D6	62.51	2.81	0.76	0.11	0.54	0.87
Mast cell, donor2	11565-120D8	97.18	15.16	1.49	3.57	0.00	2.38
Mast cell, donor3	11566-120D9	101.76	7.65	1.80	3.38	1.58	0.90
Mast cell, donor4	11567-120E1	92.90	11.70	1.06	3.72	0.89	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	68.53	1.77	0.11	0.33	0.33	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	59.54	2.33	0.00	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	52.66	1.03	1.26	0.00	0.23	0.46
Mast cell, expanded, donor8	11941-126A6	74.48	1.84	2.18	0.00	0.17	1.00
Melanocyte - dark, donor1	11502-119F8	38.70	0.80	0.50	0.10	0.00	0.30
Melanocyte - dark, donor2	11582-120F7	23.53	0.35	0.00	0.35	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	121.12	2.61	0.51	2.90	0.94	1.23
Melanocyte - light, donor1	11274-116H5	127.88	2.12	0.00	2.82	0.47	0.71
Melanocyte - light, donor2	11351-117H1	148.10	2.73	2.73	0.00	2.05	2.73
Melanocyte - light, donor3	11423-118G1	71.11	1.73	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	67.37	2.50	0.73	0.73	1.04	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	71.54	1.08	0.00	0.81	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	102.59	1.07	0.54	0.00	0.27	0.27
Meningeal Cells, donor1	11493-119E8	139.44	1.24	1.12	2.36	0.00	0.50
Meningeal Cells, donor2	11573-120E7	84.95	0.88	0.00	1.32	0.00	0.00
Meningeal Cells, donor3	11654-122E7	64.71	0.65	0.33	1.87	0.00	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	32.79	0.00	0.00	2.28	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	41.86	1.31	0.50	1.71	0.00	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	73.59	0.00	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	56.25	0.00	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	28.70	0.00	0.72	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	49.55	3.18	0.21	1.27	0.42	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	47.25	0.50	1.01	0.00	0.00	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	58.45	0.22	0.66	0.66	0.00	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	59.18	0.73	1.46	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	63.84	0.61	0.20	1.84	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	34.49	1.11	0.83	0.69	0.00	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	65.42	1.12	0.00	0.37	0.00	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	42.89	1.18	1.05	0.53	0.26	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	40.36	0.59	1.48	0.59	0.59	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	44.38	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	41.63	0.00	1.28	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	32.96	0.35	0.00	1.77	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	31.90	0.94	0.31	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	24.67	0.00	0.00	2.18	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	44.28	1.33	1.33	3.45	0.27	0.80
Mesothelial Cells, donor2	12156-128G5	28.53	1.00	0.50	1.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	52.61	1.59	0.65	3.54	0.79	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	35.11	6.75	1.35	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	38.67	0.99	0.25	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	46.23	1.77	0.00	2.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	33.47	1.24	0.31	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	34.43	0.62	0.00	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	37.06	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	38.04	3.00	0.25	0.75	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	45.15	0.93	0.47	1.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	35.36	1.42	0.41	0.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	46.33	2.38	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	19.47	0.88	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	37.23	1.14	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	26.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	31.20	1.70	0.00	1.27	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	19.34	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	29.21	2.68	0.30	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	38.14	1.00	0.00	0.75	0.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	40.88	0.24	0.24	0.71	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	27.09	0.00	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	31.54	0.69	0.23	0.92	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	47.12	0.00	0.21	0.63	0.00	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	43.62	0.61	0.00	1.43	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	29.82	0.21	0.00	1.07	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	49.79	0.44	0.00	1.11	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	34.60	0.22	0.00	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	51.71	0.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	38.11	0.00	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	32.89	0.54	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	48.52	0.29	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	40.34	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	23.55	0.48	0.00	2.40	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	45.63	0.40	0.00	2.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	43.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	43.55	0.50	0.00	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	38.73	2.04	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	42.48	0.44	0.00	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	55.18	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	52.51	1.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	48.10	0.74	0.00	1.49	0.00	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	51.50	1.39	0.00	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	75.14	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	44.79	0.34	0.34	1.37	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	51.64	0.44	0.00	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	50.78	0.00	0.00	1.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	52.46	0.28	0.00	1.12	0.00	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	63.59	0.83	0.42	2.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	52.45	0.00	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	54.30	0.00	0.00	1.21	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	80.14	0.00	0.00	0.83	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	36.94	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	69.43	0.00	0.00	1.71	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	48.36	0.69	0.28	0.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	48.98	0.26	0.00	0.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	68.21	0.43	0.43	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	43.19	1.27	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	53.11	1.07	0.00	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	52.38	2.10	0.60	0.90	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	41.95	0.99	0.14	0.71	0.00	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	41.41	0.64	0.00	0.32	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	56.61	0.66	0.22	0.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	40.20	0.00	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	48.30	1.14	0.00	0.85	0.00	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	59.48	0.74	0.00	0.49	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	35.84	3.91	1.30	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	43.81	0.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	57.38	0.58	0.58	0.86	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	52.75	2.06	0.82	2.06	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	48.54	0.60	0.30	1.19	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	1.78	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	30.23	1.64	1.31	0.00	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	2.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	18.78	2.57	1.19	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	23.28	1.86	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	19.90	2.63	0.75	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	19.98	1.33	0.53	0.27	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	20.25	1.81	0.90	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	18.42	4.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	30.78	3.30	0.37	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	9.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	9.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	27.27	2.02	0.00	0.00	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	19.40	0.42	0.42	0.42	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	6.81	12.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	3.18	1.27	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	1.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	16.61	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	91.36	79.94	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	81.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	52.28	28.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	45.24	1.29	0.00	2.37	0.00	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	41.29	1.05	1.05	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.68	0.67	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.28	0.83	0.83	0.83	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	27.38	2.66	0.76	3.99	0.00	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	73.41	1.60	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.80	0.68	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	11.03	0.00	1.84	12.86	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.02	1.26	1.26	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	18.60	1.86	0.00	0.70	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.54	2.70	1.08	0.00	0.54	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	37.42	2.52	0.42	1.05	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	11.13	0.00	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	17.37	2.98	0.50	0.00	0.00	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.10	2.44	0.81	0.54	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.97	1.36	1.36	0.23	0.00	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.53	1.96	1.31	0.33	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	38.09	2.00	1.46	0.55	0.00	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	17.50	3.71	1.06	0.00	0.53	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.00	3.00	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.72	3.94	0.33	2.30	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.41	1.79	2.11	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	52.39	2.47	2.12	0.53	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	1.41	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	12.41	3.68	1.84	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	12.53	1.61	1.93	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	20.35	4.83	0.34	1.38	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	35.40	5.06	0.00	15.17	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	37.87	6.24	1.34	1.56	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.47	2.96	1.27	0.42	0.00	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.61	3.56	1.19	0.47	0.24	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	10.30	1.72	0.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	54.17	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	13.66	2.33	1.33	0.67	0.00	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	26.60	3.61	0.90	1.35	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.33	1.19	0.40	0.79	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	2.79	0.93	0.93	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	12.86	1.89	3.03	0.38	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	15.97	1.96	0.33	0.33	0.00	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	18.30	3.05	0.44	0.44	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	47.94	2.26	1.36	0.90	0.00	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	9.70	0.88	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.30	0.66	1.33	0.66	0.00	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.94	4.96	1.49	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.40	2.30	0.77	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.13	2.42	0.30	0.30	0.00	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	39.12	2.43	0.44	1.55	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	7.45	2.71	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	5.11	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.75	3.05	1.83	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	15.74	1.89	0.31	0.94	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.22	2.72	1.82	0.00	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	0.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	14.74	2.27	0.00	5.67	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	35.53	1.24	0.75	2.48	0.00	0.37
Myoblast, donor2	11322-117D8	44.49	1.53	0.38	2.49	0.00	0.38
Myoblast, donor3	11398-118D3	54.65	0.17	0.67	3.20	0.00	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	48.60	0.73	1.31	0.73	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	163.29	4.61	2.46	8.92	17.84	2.46
Natural Killer Cells, donor2	11311-117C6	124.84	4.22	1.21	15.38	62.12	5.73
Natural Killer Cells, donor3	11387-118C1	140.43	4.79	0.74	11.60	17.12	3.68
Neural stem cells, donor1	11275-116H6	76.94	2.90	0.73	1.45	0.00	0.00
Neural stem cells, donor2	11352-117H2	100.13	3.85	1.93	5.78	0.00	1.93
Neurons, donor1	11494-119E9	40.96	3.41	4.55	1.14	0.00	0.00
Neurons, donor2	11574-120E8	40.73	0.88	4.62	1.10	0.00	0.22
Neurons, donor3	11655-122E8	22.20	4.11	3.29	0.82	0.00	0.82
Neutrophils, donor1	11233-116C9	129.92	11.14	3.71	1.86	1.86	0.00
Neutrophils, donor2	11314-117C9	113.06	2.90	0.00	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	179.59	12.83	3.05	0.61	2.44	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	63.64	1.54	0.12	0.47	0.00	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	37.44	1.95	0.33	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	24.47	1.40	1.00	0.40	0.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	31.25	2.75	1.38	2.06	0.00	1.38
Olfactory epithelial cells, donor2	11934-125I8	37.34	1.01	1.01	2.75	0.00	1.88
Olfactory epithelial cells, donor3	11935-125I9	36.66	2.84	1.25	1.02	0.00	1.02
Olfactory epithelial cells, donor4	11936-126A1	44.51	1.66	0.39	2.14	0.68	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	61.99	1.20	0.00	6.02	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	53.81	1.28	0.64	0.85	0.00	0.85
Osteoblast - differentiated, donor2	11353-117H3	24.01	1.14	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	21.72	1.24	0.00	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	60.98	1.17	0.00	1.76	0.00	0.39
Osteoblast, donor2	11354-117H4	59.70	0.00	0.70	2.81	0.00	0.00
Osteoblast, donor3	11426-118G4	55.99	0.89	0.18	3.55	0.00	0.53
Pancreatic stromal cells, donor1	11249-116E7	47.76	1.85	0.42	1.77	0.00	0.67
Pericytes, donor1	11491-119E6	113.49	3.56	1.22	0.45	0.00	0.67
Pericytes, donor2	11571-120E5	59.53	2.04	0.91	0.45	0.00	0.00
Pericytes, donor3	11652-122E5	57.37	0.41	0.61	2.03	0.20	0.41
Perineurial Cells, donor1	11499-119F5	52.33	0.68	1.02	3.16	0.00	0.11
Perineurial Cells, donor2	11579-120F4	35.15	0.64	0.37	0.37	0.09	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	151.40	2.87	2.23	1.27	16.26	3.82
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	107.49	3.67	1.47	2.20	5.88	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	133.82	3.11	1.68	3.24	17.60	3.62
Placental Epithelial Cells, donor1	11278-116H9	57.40	2.63	0.96	3.35	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	57.66	0.00	0.00	3.33	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	70.87	1.57	0.59	4.12	1.57	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	21.20	0.63	0.95	2.22	0.00	0.95
Preadipocyte - breast, donor1	11467-119B9	36.77	0.19	0.19	2.06	0.00	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	88.24	1.44	1.83	2.09	0.78	1.04
Preadipocyte - breast, donor2	11328-117E5	43.90	1.13	2.25	1.80	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	47.53	0.75	0.96	2.45	1.49	0.64
Preadipocyte - omental, donor2	11329-117E6	47.58	0.00	1.75	1.75	0.87	0.87
Preadipocyte - omental, donor3	11403-118D8	51.71	0.43	1.15	2.01	0.14	0.43
Preadipocyte - perirenal, donor1	11469-119C2	29.53	0.00	0.98	0.98	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	93.98	0.61	0.00	6.14	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	68.53	0.71	0.00	3.72	0.00	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	33.21	0.51	0.00	2.55	0.00	0.34
Preadipocyte - visceral, donor1	11280-116I2	56.35	0.56	0.37	3.73	0.19	0.37
Preadipocyte - visceral, donor2	11357-117H7	42.80	0.00	0.00	0.46	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	35.94	0.42	0.10	2.30	0.00	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	57.02	3.62	1.06	0.75	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	47.94	0.54	0.68	4.74	0.00	0.68
Prostate Epithelial Cells, donor3	11404-118D9	37.54	3.31	2.69	1.47	0.00	0.43
Prostate Stromal Cells, donor1	11254-116F3	42.26	0.68	0.46	1.59	0.00	0.57
Prostate Stromal Cells, donor2	11332-117E9	52.71	1.61	0.00	2.51	0.00	0.90
Prostate Stromal Cells, donor3	11405-118E1	38.37	1.25	0.83	0.94	0.00	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	89.06	2.55	0.00	6.20	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	52.26	1.59	0.42	3.47	0.00	0.21
Renal Epithelial Cells, donor1	11517-119H5	113.62	3.04	1.01	5.58	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	59.04	2.13	0.71	3.56	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	58.23	1.59	0.74	7.62	0.00	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	63.32	0.68	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	50.54	0.40	0.54	0.00	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	46.84	0.22	0.22	1.11	0.00	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	65.21	0.67	0.00	0.00	0.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	87.38	1.32	0.66	4.62	0.00	0.88
Renal Mesangial Cells, donor2	11598-120H5	68.34	1.88	1.25	2.51	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	73.24	2.77	0.55	1.39	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	70.86	1.34	0.54	2.42	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	44.70	1.69	0.00	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	61.33	0.39	1.35	2.89	0.00	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	43.04	0.52	1.30	0.78	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	71.35	2.56	1.71	0.57	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	46.31	1.03	0.00	3.09	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	30.36	0.50	0.75	0.50	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	62.01	3.07	2.94	0.13	0.00	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	31.27	3.57	1.79	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	33.02	1.65	1.65	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	51.62	9.28	1.16	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	45.25	1.95	1.17	0.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	37.44	1.29	0.99	0.30	0.00	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	51.75	1.00	1.00	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	49.49	1.86	1.12	0.99	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	45.80	1.05	1.40	0.23	0.00	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	55.01	2.77	1.85	0.23	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	39.43	1.64	0.41	0.82	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	41.15	1.51	1.51	0.15	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	43.18	1.25	1.43	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	43.04	3.30	1.72	0.14	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	44.86	1.29	1.18	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	49.34	1.11	1.11	0.22	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	32.12	2.49	1.15	0.38	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	37.36	1.40	1.30	0.56	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	58.44	2.44	1.88	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	37.29	1.73	0.53	0.40	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	46.53	1.65	1.27	0.68	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	50.03	2.48	2.29	1.15	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	35.46	2.14	1.39	0.43	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	39.24	1.68	0.56	0.56	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	47.68	1.88	1.20	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	30.81	1.64	0.55	0.55	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	45.99	1.96	2.33	0.61	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	42.04	1.34	1.61	0.27	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	35.38	2.12	1.65	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	48.02	1.59	0.99	0.79	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	45.13	2.34	0.70	0.47	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	36.29	1.45	0.62	0.83	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	40.92	1.77	1.33	0.66	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	43.24	2.30	1.25	0.84	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	42.66	1.21	1.35	0.67	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	38.49	1.70	0.85	0.85	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	48.78	3.47	0.96	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	38.86	2.58	0.34	1.20	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	37.17	1.51	0.82	0.82	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	47.28	1.81	0.82	0.49	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	36.81	1.87	1.02	0.68	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	46.16	1.48	1.63	0.74	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	49.05	4.26	2.93	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	33.88	2.90	2.63	0.41	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	35.72	0.95	0.48	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	66.31	4.64	1.61	0.20	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	35.50	3.86	1.88	0.09	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	44.37	1.75	2.10	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	34.45	3.32	1.21	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	37.08	4.04	0.98	0.61	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	102.47	10.48	4.37	1.16	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	40.76	3.04	1.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	25.02	2.41	0.30	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	52.25	4.30	2.49	0.45	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	50.02	6.89	2.70	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	47.47	5.08	2.36	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	48.45	4.27	2.77	0.00	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	56.49	5.41	0.60	0.60	0.00	0.60
Schwann Cells, donor1	11498-119F4	57.17	0.19	1.88	1.88	0.00	0.75
Schwann Cells, donor2	11578-120F3	20.41	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	33.96	0.22	0.88	1.10	0.00	1.10
Sebocyte, donor1	11220-116B5	243.21	2.19	2.19	10.41	0.00	0.55
Sebocyte, donor2	11301-117B5	106.62	1.38	0.00	3.22	0.00	0.92
Sebocyte, donor3	11378-118B1	80.59	2.06	0.41	2.06	0.00	0.62
Sertoli Cells, donor1	11255-116F4	34.79	1.66	0.00	4.97	0.00	0.00
Sertoli Cells, donor2	11333-117F1	33.89	0.00	0.00	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	38.45	1.14	1.32	0.18	0.00	0.18
Skeletal Muscle Cells, donor2	11358-117H8	29.64	3.61	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	65.21	0.00	0.00	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	33.30	0.47	0.47	0.16	0.00	0.31
Skeletal Muscle Cells, donor5	11455-119A6	30.03	0.45	0.30	0.30	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	37.09	0.77	0.15	0.92	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	42.34	1.13	0.63	1.13	0.00	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	39.95	1.28	0.43	0.86	0.00	1.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	49.21	0.20	0.20	1.39	0.20	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	47.69	0.67	0.34	0.84	0.00	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	53.56	0.72	0.00	2.17	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	29.45	0.28	0.55	0.69	0.00	0.28
Skin - palm, donor1	10286-104F7	77.90	8.06	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	21.62	0.43	0.29	2.74	0.00	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	166.03	1.64	2.45	22.08	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.08	0.39	0.13	1.04	0.00	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	41.42	2.09	1.25	4.73	0.00	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	50.36	0.42	0.56	6.47	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	180.57	5.50	3.38	17.13	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	49.62	4.05	1.05	1.65	0.00	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	26.54	0.31	0.93	3.70	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	47.80	2.22	2.45	1.78	0.00	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	52.90	0.59	0.59	2.94	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	56.13	0.44	0.66	1.99	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	75.21	0.39	0.39	5.12	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	52.53	0.77	0.00	6.18	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	41.03	1.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	55.63	0.67	0.13	2.66	0.00	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	34.13	0.66	0.00	0.44	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	17.28	0.77	0.13	1.54	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.98	0.65	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	45.18	0.30	0.30	1.18	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	35.16	0.57	0.57	0.57	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	70.60	0.65	0.33	1.95	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	22.83	0.91	0.00	0.61	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	61.37	0.25	0.25	1.52	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	34.33	0.95	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	31.26	0.74	0.74	0.59	0.00	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	30.35	1.94	1.51	0.43	0.00	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	37.47	0.84	0.42	0.21	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	80.59	0.62	0.46	4.49	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	49.58	1.08	1.08	4.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	27.79	0.60	0.60	2.39	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	75.45	0.68	0.68	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	42.33	1.57	2.28	0.55	0.00	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	52.23	0.91	0.60	4.63	0.00	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	53.02	0.46	1.14	2.28	0.46	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	45.89	0.00	0.00	3.02	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	51.66	0.26	0.00	1.06	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	44.34	1.60	0.53	1.33	0.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	33.18	1.75	0.63	0.13	0.00	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	29.42	0.00	0.76	1.01	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	57.60	0.75	0.45	5.88	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	43.51	1.50	0.75	3.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	67.20	0.00	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	67.44	0.00	1.40	2.79	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	46.45	0.00	0.50	1.51	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	34.47	1.25	0.63	2.51	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	45.43	0.88	0.29	1.47	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	49.65	0.33	0.42	3.33	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	25.23	1.87	0.93	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	70.09	1.44	1.15	5.61	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	69.60	0.76	0.25	4.08	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	45.88	0.56	0.38	0.94	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	34.66	0.56	0.42	1.82	0.00	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	31.76	0.50	0.42	1.17	0.00	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	48.57	0.95	0.95	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	74.62	1.22	0.49	6.85	0.00	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	42.20	1.99	0.00	3.54	0.44	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	38.91	1.76	0.29	1.76	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	22.35	1.17	0.39	0.97	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	26.45	1.85	0.00	1.32	0.00	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	21.20	2.23	0.37	0.74	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	52.10	1.80	0.72	1.80	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	48.55	1.99	0.85	1.14	0.00	1.70
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	37.02	0.79	0.39	1.97	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	28.19	0.76	0.51	1.52	0.00	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	22.36	0.80	0.80	0.80	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	24.24	0.00	0.00	0.00	0.00	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	22.46	0.92	0.00	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	38.04	0.67	0.17	6.40	0.00	0.34
Synoviocyte, donor2	11368-117I9	36.54	1.34	0.34	1.68	0.50	0.67
Synoviocyte, donor3	11440-118H9	29.94	2.01	0.45	1.56	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	78.26	1.79	1.43	0.00	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	59.46	0.00	1.98	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	62.52	1.39	0.93	0.69	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	71.25	1.00	0.65	3.66	0.00	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	71.90	1.16	0.39	3.87	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	53.83	1.72	0.57	1.15	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	62.25	4.06	2.46	0.12	0.12	0.12
Urethra, donor2	10319-105A4	48.56	8.99	7.19	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	104.14	0.80	0.27	11.69	0.00	1.06
Urothelial Cells, donor2	11600-120H7	62.49	0.00	0.00	9.21	0.00	1.20
Urothelial Cells, donor3	11681-122H7	72.20	2.29	0.92	8.71	0.00	0.23
Urothelial cells, donor0	11216-116B1	80.02	0.67	0.45	17.39	0.00	2.23
Whole blood (ribopure), donor090309, donation1	12179-129A1	113.00	2.67	6.23	0.00	12.46	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	122.95	0.00	8.58	0.00	12.87	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	81.46	1.37	2.74	0.00	10.27	4.11
Whole blood (ribopure), donor090325, donation1	12176-128I7	105.37	2.41	4.13	0.00	9.99	2.75
Whole blood (ribopure), donor090325, donation2	12177-128I8	92.38	1.74	4.65	0.00	14.53	2.91
Whole blood (ribopure), donor090612, donation1	12182-129A4	102.04	1.04	3.12	1.04	11.45	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	122.98	2.75	1.84	0.00	11.93	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	88.55	3.65	5.48	0.00	9.13	1.83
Wilms' tumor cell line:G-401	10809-111A8	32.32	3.21	2.22	0.00	0.00	0.12
Wilms' tumor cell line:HFWT	10597-108E3	34.32	5.28	4.40	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	59.77	1.40	0.28	0.56	0.00	1.12
achilles tendon, donor2	10292-104G4	41.33	0.00	0.00	8.27	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	41.05	0.00	0.25	0.25	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	71.51	0.23	0.23	0.00	0.00	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	87.25	1.90	1.07	0.12	0.00	1.19
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	47.62	1.63	1.09	0.00	0.00	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	48.07	1.41	0.56	0.00	0.00	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	46.95	1.27	0.85	0.00	0.00	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	90.37	2.72	1.63	2.18	0.00	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	40.54	3.97	1.32	0.00	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	102.09	5.31	3.27	0.00	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	79.99	2.72	1.16	0.00	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	34.04	0.00	1.47	0.00	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	105.31	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	76.45	2.79	0.46	0.46	0.00	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	68.09	1.04	2.33	0.26	0.00	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	52.90	1.17	2.05	0.00	0.00	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	58.09	3.72	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	49.35	1.23	2.06	0.82	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	22.41	0.92	1.84	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	70.83	2.13	2.13	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	81.28	4.55	4.85	0.00	0.00	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	75.58	1.68	2.17	0.00	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	40.76	2.23	1.56	0.00	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	42.03	6.00	1.33	0.67	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	68.75	1.86	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	70.44	1.88	2.26	0.00	0.00	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	88.97	5.67	3.05	0.00	0.00	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	35.61	7.50	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	47.10	8.95	2.59	0.24	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	63.13	1.71	1.71	0.62	0.78	0.16
adipose, donor1	10184-103D4	45.74	4.69	4.69	0.59	0.00	1.17
adipose, donor2	10185-103D5	32.85	3.24	5.68	0.00	0.00	0.00
adipose, donor3	10186-103D6	21.24	4.63	7.90	0.00	0.00	0.00
adipose, donor4	10187-103D7	21.67	0.87	3.47	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	28.25	4.26	3.00	0.00	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	40.01	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	76.58	2.80	0.53	0.67	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	27.51	1.43	0.36	0.00	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	84.39	3.25	1.39	6.49	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	80.13	6.09	2.70	1.35	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	94.57	4.71	4.71	3.24	0.29	0.29
amygdala - adult, donor10196	10167-103B5	62.85	3.56	7.11	2.37	0.00	1.19
amygdala, adult, donor10252	10151-102I7	95.50	8.31	9.12	3.65	0.81	0.20
amygdala, newborn, donor10223	10360-105E9	25.82	4.84	3.23	4.84	0.97	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	60.61	3.57	2.80	1.91	0.00	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	42.80	2.21	1.10	1.76	0.66	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	61.13	7.01	3.01	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	53.15	4.12	2.16	3.92	0.00	0.98
appendix, adult	10189-103D9	75.29	4.66	1.94	0.78	3.10	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	32.33	1.72	2.06	0.34	0.00	0.00
artery, adult	10190-103E1	32.61	1.36	5.43	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	97.35	5.50	2.03	2.75	0.00	1.16
b cell line:RPMI1788	10427-106D4	92.05	0.15	0.30	0.15	0.00	1.04
basal cell carcinoma cell line:TE 354.T	10702-109G9	69.92	1.66	1.66	5.83	0.00	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	58.15	1.59	2.08	1.19	0.00	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	41.68	4.35	6.19	0.33	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	43.62	1.12	2.80	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	64.86	1.63	1.20	1.52	1.09	0.54
blood, adult, pool1	10053-101G8	33.22	6.64	2.21	0.00	6.64	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	68.51	2.57	0.86	0.86	0.00	0.00
bone marrow, adult	10192-103E3	62.76	4.05	3.37	1.35	0.00	2.02
brain, adult, donor1	10084-102B3	37.93	4.10	4.10	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	60.36	3.01	5.01	1.45	0.89	0.33
brain, fetal, pool1	10085-102B4	45.41	10.69	8.01	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	38.98	2.97	2.31	0.33	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	90.00	13.36	3.50	0.62	0.00	0.37
breast, adult, donor1	10080-102A8	16.42	4.42	2.53	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	43.07	3.43	3.30	0.00	0.00	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	61.84	3.09	2.78	3.09	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	49.27	16.35	2.30	0.23	0.00	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	101.68	7.26	4.12	0.48	0.00	1.21
carcinoid cell line:NCI-H1770	10703-109H1	35.26	0.94	4.70	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	67.49	7.22	4.92	0.22	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	37.71	2.85	3.80	0.00	0.00	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	66.54	6.12	2.93	0.00	0.00	0.53
caudate nucleus - adult, donor10196	10177-103C6	66.78	11.51	6.91	3.45	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	104.75	7.86	10.88	8.37	0.33	0.50
caudate nucleus, adult, donor10258	10379-105H1	48.14	14.52	9.17	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	39.19	5.49	4.76	3.30	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	119.44	8.74	49.53	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	119.57	6.83	43.34	0.00	0.21	0.43
cerebellum, adult, pool1	10083-102B2	33.11	6.21	11.73	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	82.20	2.49	6.64	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	41.35	3.03	3.28	1.01	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	21.20	0.73	2.19	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	39.54	3.02	5.18	0.14	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	42.92	2.65	1.66	0.83	0.00	0.17
cervix, adult, pool1	10013-101C4	68.56	3.15	3.36	0.52	1.47	1.47
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	33.44	2.23	0.98	0.42	0.00	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	26.13	5.23	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	84.26	1.24	1.86	0.25	0.00	0.25
choriocarcinoma cell line:SCH	10785-110H2	103.99	1.97	2.34	0.00	0.00	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	124.52	2.37	6.88	0.00	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	59.55	2.56	1.42	2.85	0.00	0.85
chorionic membrane cells, donor2	12239-129G7	68.71	1.89	0.89	1.29	0.10	0.50
chorionic membrane cells, donor3	12240-129G8	75.83	1.65	1.65	2.20	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	21.21	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	63.20	2.31	0.96	0.19	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	59.55	1.90	2.75	0.00	0.00	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	200.56	5.39	3.60	0.00	0.00	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	231.96	7.01	5.08	0.00	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	237.21	8.14	2.44	0.61	0.00	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	132.80	3.24	2.94	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	69.07	1.30	1.82	0.00	0.00	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	68.12	4.80	1.60	0.91	0.00	0.91
clear cell carcinoma cell line:TEN	10636-108I6	25.16	1.39	0.52	0.35	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	51.25	1.10	1.28	0.18	0.00	0.55
colon carcinoma cell line:COLO-320	10420-106C6	77.54	7.60	5.32	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	52.36	4.76	8.33	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	81.19	3.17	3.88	0.24	0.59	0.71
colon, fetal, donor1	10070-101I7	26.57	6.80	3.09	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	169.59	9.17	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	67.56	9.35	0.00	0.00	4.25	18.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	48.90	2.57	0.00	0.30	1.06	6.49
cord blood derived cell line:COBL-a untreated	10449-106F8	44.14	2.68	0.00	0.28	1.41	6.20
corpus callosum, adult, pool1	10042-101F6	107.02	7.74	12.71	0.77	0.88	0.55
cruciate ligament, donor2	10295-104G7	75.37	4.86	0.00	2.43	0.00	1.62
diaphragm, fetal, donor1	10069-101I6	20.06	4.01	4.82	0.80	0.00	0.80
diencephalon, adult	10193-103E4	30.48	2.64	3.84	0.24	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	37.43	0.23	0.23	0.00	0.00	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	113.86	6.15	5.13	0.00	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	33.22	6.98	4.09	0.72	0.00	0.00
ductus deferens, adult	10196-103E7	54.82	3.49	5.98	0.00	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	2.88	7.20	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	77.24	5.89	2.94	1.47	0.74	2.21
dura mater, adult, donor1	10041-101F5	103.89	1.32	1.73	2.97	0.58	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	113.04	4.66	1.55	6.44	0.00	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	59.47	4.30	2.87	0.29	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	40.70	4.93	3.70	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	46.92	3.94	1.51	0.30	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	39.52	2.16	1.23	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	70.93	9.19	5.25	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	64.69	5.70	1.68	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	48.93	4.53	1.45	0.36	0.00	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	38.76	1.45	0.32	0.32	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	92.93	3.56	0.89	2.78	0.00	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	107.46	3.08	3.63	7.70	0.00	0.66
epididymis, adult	10197-103E8	50.23	1.67	2.30	0.21	0.63	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	42.93	6.03	2.13	1.60	0.00	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	14.16	1.18	0.39	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	34.60	2.49	3.01	0.39	0.00	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	42.22	2.85	3.15	0.20	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	36.41	2.58	2.46	0.22	0.00	0.11
esophagus, adult, pool1	10015-101C6	51.92	2.02	2.02	0.11	0.32	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	56.48	20.54	2.38	0.00	0.00	0.38
eye - muscle inferior rectus, donor1	10272-104E2	55.54	14.49	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	33.67	2.10	6.31	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	40.18	4.46	4.46	1.49	1.49	0.00
eye - muscle superior, donor2	10297-104G9	37.83	3.44	3.44	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	36.43	7.29	1.46	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	40.42	4.07	5.08	0.25	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	62.70	2.44	1.54	0.77	0.00	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	65.05	2.85	1.90	0.47	0.00	0.95
frontal lobe, adult, pool1	10040-101F4	91.10	4.88	7.98	2.72	0.38	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	63.05	3.30	2.10	0.60	0.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	67.39	4.02	0.64	1.55	0.00	0.37
gall bladder, adult	10198-103E9	61.08	4.10	1.93	0.48	1.93	0.97
gamma delta positive T cells, donor1	11937-126A2	97.71	1.61	0.54	0.00	25.77	2.15
gamma delta positive T cells, donor2	11938-126A3	81.79	3.36	0.37	0.00	6.35	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	36.12	0.00	0.42	0.00	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	34.04	1.35	0.77	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	44.10	7.54	6.23	0.00	0.00	0.33
gastric cancer cell line:GSS	10560-108A2	19.22	2.75	1.83	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	39.07	3.88	1.14	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	16.29	0.80	0.80	0.11	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	76.42	4.06	0.98	0.84	0.00	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	55.62	3.74	2.49	0.25	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	49.82	1.48	0.84	2.01	0.00	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	41.43	1.26	0.84	0.84	0.00	0.28
glioblastoma cell line:T98G	10485-107A8	65.56	1.88	1.21	0.44	0.00	0.66
glioma cell line:GI-1	10413-106B8	65.02	1.46	1.46	0.88	0.00	0.88
globus pallidus - adult, donor10196	10175-103C4	38.63	8.75	10.93	2.19	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	106.67	9.52	9.28	0.98	0.98	0.73
globus pallidus, adult, donor10258	10367-105F7	30.12	2.74	5.48	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	27.18	1.07	2.13	0.53	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	269.19	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	29.76	2.56	0.64	0.00	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	24.33	0.00	0.92	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	29.26	0.91	1.37	0.00	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	30.92	1.29	0.64	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	25.87	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	20.58	1.37	1.37	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	25.38	4.41	4.41	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	52.87	0.86	0.00	0.57	2.01	1.15
heart - mitral valve, adult	10205-103F7	53.52	2.39	2.69	0.90	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	62.75	2.35	7.58	0.26	0.26	0.52
heart - tricuspid valve, adult	10207-103F9	59.12	2.50	0.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	39.59	3.88	1.22	0.20	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	39.18	1.28	2.13	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	32.89	0.69	2.76	0.00	0.46	0.00
heart, fetal, pool1	10046-101G1	96.83	2.98	4.00	0.21	0.10	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	47.51	0.93	0.62	4.32	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	52.32	5.95	3.57	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	63.20	1.55	0.77	0.66	0.00	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	61.66	1.34	1.09	0.49	0.00	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	73.47	2.53	1.21	0.20	0.00	0.10
hepatoma cell line:Li-7	10484-107A7	31.92	2.11	0.89	0.00	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	41.10	1.01	0.20	0.20	0.00	0.50
hippocampus - adult, donor10196	10169-103B7	65.30	3.79	6.62	5.68	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	92.05	7.76	12.25	3.27	0.82	0.61
hippocampus, adult, donor10258	10374-105G5	39.84	3.98	5.48	1.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	25.73	2.11	2.47	2.11	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	28.69	0.61	1.83	0.00	0.00	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	22.58	1.18	1.77	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	28.18	1.02	0.76	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	24.81	3.38	6.77	0.00	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	26.60	3.36	7.75	0.00	0.00	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	35.68	4.18	3.80	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	42.33	7.59	4.09	0.00	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	41.58	8.40	6.03	0.00	0.00	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	40.46	7.51	4.17	0.00	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	36.70	6.16	3.79	0.47	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	31.18	5.46	5.46	0.00	0.00	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	30.97	6.73	2.69	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	25.19	1.88	1.10	0.00	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	23.09	0.49	0.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	16.58	0.87	1.75	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	38.95	4.58	7.06	0.00	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	32.71	5.23	9.16	0.00	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	30.99	4.00	6.00	0.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	47.47	3.77	3.58	0.00	0.00	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	48.65	4.09	7.28	0.45	0.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	37.28	4.70	5.01	0.00	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	27.76	3.27	6.53	0.33	0.00	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	29.32	4.06	6.68	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	29.00	4.48	7.17	0.00	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	21.80	0.74	1.11	0.00	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	27.67	1.43	1.14	0.00	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	22.87	0.82	3.27	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	41.19	4.93	5.63	0.00	0.00	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	39.59	5.07	5.38	0.00	0.00	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	36.92	6.66	2.72	0.00	0.00	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	41.89	5.17	3.62	0.52	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	35.86	5.31	4.65	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	46.43	2.82	3.33	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	39.63	3.58	3.58	0.00	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	38.62	6.06	7.57	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	26.88	5.38	3.02	0.34	0.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	28.50	0.72	1.93	0.24	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	24.07	0.45	2.67	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	30.73	0.00	0.98	0.00	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	51.96	5.50	7.03	0.00	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	42.29	26.03	3.25	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	38.06	9.93	3.64	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	52.54	6.02	8.21	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	36.55	3.98	1.81	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	25.27	6.05	2.85	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	22.67	7.16	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	50.24	4.88	6.09	0.54	0.00	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	26.67	2.42	4.85	0.00	0.00	0.81
immature langerhans cells, donor1	11904-125F5	87.17	1.94	0.00	5.81	0.00	0.48
immature langerhans cells, donor2	11905-125F6	72.88	6.34	0.00	4.75	0.00	0.00
insula, adult, pool1	10039-101F3	111.19	7.00	8.23	5.11	0.66	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	29.91	3.90	0.98	0.00	0.00	0.33
kidney, adult, pool1	10017-101C8	55.67	2.70	2.30	0.00	0.20	0.30
kidney, fetal, pool1	10045-101F9	94.57	4.88	5.02	0.35	0.00	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	49.57	1.14	0.99	2.13	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	17.83	1.94	2.35	0.28	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	61.47	4.77	2.57	0.73	0.00	0.18
left atrium, adult, donor1	10079-102A7	21.79	1.63	2.72	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	15.17	0.51	1.52	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	26.54	1.92	0.27	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	22.99	0.36	0.72	4.31	0.36	2.51
leiomyoma cell line:15242A	10570-108B3	20.65	0.00	0.54	4.35	0.00	1.09
leiomyoma cell line:15425	10571-108B4	41.52	1.70	0.49	6.56	0.49	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	39.73	1.05	3.14	4.18	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	57.97	2.01	3.42	0.35	0.00	0.35
liposarcoma cell line:KMLS-1	10782-110G8	62.17	1.72	0.78	4.06	0.00	0.47
liposarcoma cell line:SW 872	10726-110A6	45.45	2.31	0.97	0.61	0.00	0.12
liver, adult, pool1	10018-101C9	28.20	0.32	0.65	0.00	0.16	0.49
liver, fetal, pool1	10086-102B5	12.23	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	47.68	5.25	6.27	4.23	0.15	0.15
locus coeruleus, adult, donor10252	10165-103B3	65.15	4.43	9.04	1.66	0.37	0.37
locus coeruleus, adult, donor10258	10375-105G6	24.55	3.39	5.64	0.56	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	34.07	2.52	2.94	5.47	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	18.54	3.60	1.80	0.00	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	64.11	9.65	1.38	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	71.44	8.70	1.85	1.32	0.13	0.00
lung, adult, pool1	10019-101D1	67.81	2.72	1.65	1.54	0.83	0.83
lung, fetal, donor1	10068-101I5	123.01	9.42	8.28	1.14	0.57	0.57
lung, right lower lobe, adult, donor1	10075-102A3	33.91	4.58	3.67	0.00	1.37	0.46
lymph node, adult, donor1	10077-102A5	24.61	0.47	0.95	0.00	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	29.59	0.22	0.00	0.00	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	52.98	0.30	0.00	0.00	0.00	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	95.99	5.10	0.85	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	67.93	2.66	2.66	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	59.15	2.70	3.32	0.42	0.21	0.42
mature adipocyte, donor3	12233-129G1	74.44	2.13	1.90	0.71	0.00	0.00
mature adipocyte, donor4	12234-129G2	54.22	2.11	2.63	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	67.19	12.15	11.44	0.00	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	75.58	9.02	6.77	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	97.10	10.85	8.46	2.76	0.55	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	33.36	7.31	3.49	0.95	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	55.02	3.41	2.13	13.22	0.00	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	68.18	6.24	8.78	2.87	0.84	1.86
medial temporal gyrus, adult, donor10252	10156-103A3	101.87	9.55	11.46	3.61	0.21	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	25.04	0.00	5.78	1.93	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	14.35	14.35	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	46.66	2.51	3.59	4.67	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	41.53	5.84	3.89	3.89	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	76.16	4.95	7.89	1.08	0.93	0.15
medulla oblongata, adult, pool1	10038-101F2	82.69	4.16	7.75	1.22	0.49	0.24
medulla oblongata, newborn, donor10223	10361-105F1	32.98	2.78	5.21	2.43	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	45.39	6.42	10.18	0.22	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	35.46	2.20	2.08	0.73	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	195.50	3.59	1.15	0.57	0.29	1.87
melanoma cell line:G-361	10465-106H6	60.54	2.71	1.36	1.09	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	33.83	1.27	0.36	0.00	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	63.44	5.29	3.52	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	59.62	3.11	3.63	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	43.27	0.00	0.15	2.92	0.15	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	37.99	1.27	0.18	4.36	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	33.13	0.83	0.41	1.66	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	39.05	2.81	0.56	2.67	0.42	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	30.43	1.54	0.19	2.31	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	44.42	2.78	0.00	2.78	0.69	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	22.66	1.37	0.86	1.03	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	34.62	1.38	0.46	2.99	1.15	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	37.93	0.53	0.27	1.59	0.27	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	35.52	1.35	0.41	2.03	0.27	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	44.67	0.85	0.43	3.27	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	39.52	0.99	0.66	0.66	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	45.11	0.97	0.28	3.46	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	51.32	1.40	0.00	2.09	0.35	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	33.69	1.02	0.41	3.67	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	50.68	0.72	0.72	3.95	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	35.59	1.76	1.14	2.69	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	48.33	0.68	0.46	2.05	0.23	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	50.35	0.42	0.42	7.55	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	39.00	1.05	0.15	2.09	0.30	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	34.14	0.70	0.70	3.06	0.26	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	42.71	0.74	1.10	0.37	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	63.81	0.86	0.86	2.58	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	47.15	1.68	0.84	2.11	0.00	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	27.40	0.00	0.46	0.91	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	36.83	0.00	1.02	0.77	0.00	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	31.15	0.79	0.79	1.83	0.52	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	30.81	0.92	0.62	1.54	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	32.24	0.94	0.00	1.18	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	32.49	1.02	0.34	1.35	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	34.97	0.00	0.00	1.18	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	33.36	0.00	0.00	1.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	38.07	0.29	0.29	1.44	0.29	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	38.15	1.34	0.00	1.12	0.22	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	37.49	0.72	0.96	0.48	1.20	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	41.07	1.47	2.20	2.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	28.87	0.67	1.01	2.35	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	25.38	0.82	0.00	2.46	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	26.20	0.86	0.86	1.29	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	24.68	1.62	0.32	0.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	26.65	0.53	0.53	1.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	26.99	0.00	0.00	1.64	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	24.49	0.39	0.39	0.39	0.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	29.38	0.00	0.00	0.00	0.00	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	31.79	0.99	0.00	0.99	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.82	1.78	0.00	1.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	38.99	0.00	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	23.44	0.00	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	21.04	1.38	0.69	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	18.34	0.41	0.81	1.22	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.92	0.00	0.00	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	24.76	0.00	0.59	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.20	0.31	0.62	0.31	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	22.72	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	1.18	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	26.16	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	19.79	0.99	1.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	17.94	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	26.08	0.00	0.64	0.00	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	22.16	2.01	2.82	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	19.01	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.85	3.64	2.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	18.94	1.65	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	19.45	0.40	0.60	0.20	0.00	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	17.85	0.97	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	31.58	1.02	0.00	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	57.25	7.74	3.87	1.55	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	79.85	1.89	1.89	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	66.03	5.10	0.46	0.46	0.23	7.18
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	14.59	0.92	0.41	1.23	0.00	0.21
mesothelioma cell line:Mero-25	10850-111F4	66.50	3.18	2.95	1.59	0.00	1.59
mesothelioma cell line:Mero-41	10851-111F5	41.32	0.98	0.24	1.22	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	36.31	1.55	0.44	0.44	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	58.87	1.05	0.79	3.42	0.00	1.58
mesothelioma cell line:Mero-83	10854-111F8	32.51	2.38	0.51	1.70	0.00	0.51
mesothelioma cell line:Mero-84	10855-111F9	39.18	1.01	0.51	0.25	0.00	1.26
mesothelioma cell line:Mero-95	10856-111G1	22.98	0.41	0.41	1.04	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	52.84	1.33	0.66	2.82	0.00	0.83
mesothelioma cell line:NCI-H226	10846-111E9	28.78	0.72	0.00	1.27	0.00	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	70.55	5.47	0.85	1.88	0.34	1.20
mesothelioma cell line:NCI-H28	10845-111E8	39.95	2.80	1.53	0.25	0.00	0.76
mesothelioma cell line:No36	10857-111G2	19.25	0.98	0.98	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	43.35	0.54	0.27	0.54	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	38.58	1.34	0.00	0.19	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	45.18	0.49	0.00	0.12	0.24	0.24
migratory langerhans cells, donor3	11903-125F4	44.69	0.90	0.00	0.00	0.00	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	20.89	0.65	0.65	0.00	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	25.86	1.27	0.21	0.42	0.00	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	90.07	9.91	7.37	2.99	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	40.72	0.57	0.00	0.19	0.76	1.52
myelodysplastic syndrome cell line:SKM-1	10772-110F7	64.68	2.59	4.25	0.37	0.00	0.18
myeloma cell line:PCM6	10474-106I6	15.42	0.79	0.59	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	43.12	0.00	0.00	2.03	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	45.31	2.16	1.77	1.57	0.00	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	26.07	3.01	3.90	0.45	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	21.92	2.79	2.28	0.51	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	50.23	0.55	0.55	2.21	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	73.62	6.44	11.04	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	65.29	1.12	1.87	0.00	0.00	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	33.32	4.64	3.59	0.00	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	81.99	3.91	4.66	0.37	0.00	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	56.22	10.44	14.95	0.00	0.00	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	51.95	5.07	5.70	0.48	0.00	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	24.15	1.81	1.81	0.00	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	50.23	6.99	5.72	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	33.27	1.06	1.33	0.80	0.00	0.00
neutrophil PMN, donor1	12133-128D9	208.25	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	122.10	1.35	0.34	0.17	0.00	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	24.02	0.80	1.60	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	23.40	2.24	0.32	0.64	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	46.25	0.26	1.31	0.79	0.00	0.79
nucleus accumbens, adult, pool1	10037-101F1	101.33	6.47	9.19	3.84	0.09	0.47
occipital cortex - adult, donor10196	10172-103C1	78.29	8.24	12.36	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	109.49	9.12	12.34	1.61	1.34	0.54
occipital cortex, newborn, donor10223	10355-105E4	56.05	2.91	2.91	5.82	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	53.79	4.99	6.56	0.79	0.26	0.52
occipital lobe, fetal, donor1	10073-102A1	42.91	2.15	12.44	0.00	0.00	0.86
occipital pole, adult, pool1	10036-101E9	79.00	3.39	5.91	2.44	0.55	0.63
olfactory region, adult	10195-103E6	61.52	5.92	7.26	2.29	0.38	0.38
optic nerve, donor1	10277-104E7	64.03	8.00	10.01	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	70.74	3.87	3.53	0.80	0.00	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	50.83	3.98	2.06	0.27	0.00	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	120.39	4.74	1.19	2.54	0.00	1.86
oral squamous cell carcinoma cell line:SAS	10544-107H4	40.20	1.50	0.12	0.81	0.00	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	43.21	0.00	0.88	2.06	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	104.65	2.80	2.80	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	36.05	1.06	1.70	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	49.97	3.23	3.41	0.17	0.70	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	61.60	3.85	2.02	6.05	0.00	0.73
pancreas, adult, donor1	10049-101G4	37.63	3.76	4.70	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	38.02	0.84	1.40	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	58.60	2.04	1.70	1.02	0.00	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	131.31	9.60	1.66	18.21	0.00	0.50
paracentral gyrus, adult, pool1	10035-101E8	88.59	3.75	6.86	2.65	0.55	0.73
parietal cortex, adult, donor10258	10373-105G4	33.03	7.34	5.14	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	51.73	8.46	11.29	1.88	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	88.93	5.99	9.69	2.28	1.71	0.57
parietal lobe, adult, pool1	10034-101E7	88.30	4.41	8.20	2.91	0.53	0.44
parietal lobe, fetal, donor1	10072-101I9	48.49	4.85	16.49	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	48.60	2.62	1.12	7.10	0.37	0.37
parotid gland, adult	10199-103F1	26.52	1.85	3.08	0.00	0.62	0.00
penis, adult	10200-103F2	60.16	1.61	1.61	0.00	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	92.60	2.05	2.97	0.00	0.00	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	206.60	10.93	4.81	1.31	0.00	1.75
pineal gland - adult, donor10196	10179-103C8	81.27	21.29	16.13	10.32	1.29	1.29
pineal gland, adult, donor10252	10160-103A7	129.10	19.54	34.35	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	61.45	15.68	15.05	0.00	0.63	1.25
pituitary gland - adult, donor10196	10180-103C9	69.81	7.08	9.11	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	126.13	9.38	29.71	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	39.16	11.92	13.62	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	87.51	6.34	5.27	0.11	0.22	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	38.27	0.40	0.13	0.26	0.00	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	49.03	2.80	1.71	0.00	0.00	0.00
pons, adult, pool1	10033-101E6	70.06	2.84	6.89	1.55	0.77	0.17
postcentral gyrus, adult, pool1	10032-101E5	87.44	4.71	7.32	1.92	0.35	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	154.76	0.00	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	92.64	5.24	2.91	1.60	0.00	1.60
prostate cancer cell line:PC-3	10439-106E7	42.83	1.63	1.82	1.45	0.00	0.54
prostate, adult, pool1	10022-101D4	57.59	3.45	4.81	0.36	0.54	0.36
putamen, adult, donor10196	10176-103C5	94.43	8.50	7.55	5.67	0.00	0.47
putamen, adult, donor10252	10152-102I8	58.82	1.96	7.84	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	32.78	4.37	3.28	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	60.40	2.90	7.97	0.24	0.00	0.48
putamen, newborn, donor10223	10365-105F5	29.99	4.50	3.00	5.25	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	305.48	26.77	20.95	1.45	0.00	0.00
rectum, fetal, donor1	10067-101I4	48.68	5.56	5.56	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	79.92	5.30	1.06	3.18	0.00	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	57.58	1.66	0.41	6.63	0.00	0.41
retina, adult, pool1	10030-101E3	102.98	6.66	10.34	0.99	0.89	0.99
retinoblastoma cell line:Y79	10475-106I7	47.54	3.38	2.60	0.00	0.00	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	28.28	4.18	1.11	0.00	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	58.21	5.91	2.25	0.00	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	58.35	2.27	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	49.85	0.97	0.49	2.10	0.00	0.32
salivary acinar cells, donor2	11772-123I8	59.48	4.13	1.10	1.79	0.00	0.55
salivary acinar cells, donor3	11773-123I9	66.87	4.63	4.63	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	61.77	3.43	8.58	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	23.44	2.19	0.76	0.25	0.00	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	21.16	0.94	1.88	0.12	0.00	0.00
seminal vesicle, adult	10201-103F3	67.19	7.41	7.94	0.00	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	43.73	7.29	0.97	1.70	0.00	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	43.53	1.51	0.25	1.01	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	74.26	2.01	0.00	6.02	0.00	4.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	93.89	1.21	3.36	0.40	0.00	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	60.79	2.43	1.44	0.55	0.00	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	44.26	3.87	0.77	0.52	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	48.23	0.00	3.55	0.71	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	80.24	0.48	4.20	0.36	0.12	0.24
skeletal muscle, fetal, donor1	10066-101I3	35.18	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	51.76	5.68	3.79	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	33.35	4.67	3.00	0.00	0.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	31.21	6.93	2.52	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	31.42	4.24	5.20	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	45.49	1.48	2.80	0.00	0.00	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	39.41	2.09	2.73	0.00	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	36.17	4.14	2.83	0.44	0.00	0.44
small intestine, adult, pool1	10024-101D6	100.33	5.14	5.97	0.48	0.96	0.72
small intestine, fetal, donor1	10064-101I1	43.00	7.86	6.14	0.00	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	24.62	1.54	1.03	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	53.50	1.81	2.33	0.52	1.29	1.03
somatostatinoma cell line:QGP-1	10781-110G7	26.80	6.16	1.88	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	37.62	5.28	5.05	1.84	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	69.39	10.25	9.86	1.97	1.58	0.00
spinal cord, adult, donor10258	10369-105F9	21.45	8.30	3.46	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	39.03	3.05	8.54	0.61	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	43.63	3.21	3.67	0.92	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	51.23	0.45	0.75	5.23	0.00	0.45
spleen, adult, pool1	10025-101D7	57.93	0.44	0.66	0.00	0.44	0.55
spleen, fetal, pool1	10044-101F8	99.40	2.86	0.79	0.16	0.56	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	83.53	0.31	0.21	0.00	0.00	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	41.01	8.73	3.23	0.00	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	48.57	5.59	1.40	0.00	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	69.59	2.35	1.17	1.56	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	44.57	2.81	3.38	1.35	0.00	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	14.83	4.24	1.27	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	55.00	1.69	0.42	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	50.19	14.95	4.27	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	58.68	0.57	3.42	0.00	2.85	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	79.14	9.55	7.27	0.21	0.21	0.21
substantia nigra, adult, donor10258	10371-105G2	29.48	5.17	7.76	1.55	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	43.81	0.71	2.83	2.12	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	46.77	2.98	3.44	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	91.30	3.65	6.95	3.65	0.34	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	54.13	4.27	21.37	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	61.54	3.08	11.87	0.88	0.00	0.88
tenocyte, donor1	11763-123H8	55.86	0.70	0.70	3.49	0.35	1.40
tenocyte, donor2	11765-123I1	42.35	1.14	0.76	3.82	0.00	1.14
tenocyte, donor3	11768-123I4	41.14	0.74	0.00	1.11	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	75.63	1.19	1.36	0.00	0.17	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	38.23	2.31	0.92	0.00	0.00	0.62
teratocarcinoma cell line:PA-1	10807-111A6	55.79	1.39	3.25	0.15	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	99.78	0.89	1.52	0.13	0.00	1.14
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	102.11	1.89	2.65	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	111.13	2.18	3.60	0.11	0.00	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	107.81	0.00	1.30	0.00	0.00	2.28
testis, adult, pool1	10026-101D8	63.56	2.15	2.79	0.54	1.50	0.75
testis, adult, pool2	10096-102C6	103.75	3.16	3.61	0.00	0.00	0.90
thalamus - adult, donor10196	10168-103B6	72.86	5.52	12.14	4.42	0.00	0.00
thalamus, adult, donor10252	10154-103A1	87.67	8.91	8.60	0.00	0.78	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	35.41	4.62	4.62	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	18.94	2.47	3.79	0.00	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	31.07	3.45	0.58	1.73	1.15	0.00
throat, adult	10209-103G2	63.17	2.50	3.99	0.25	0.25	0.00
throat, fetal, donor1	10061-101H7	32.30	4.27	5.48	0.00	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	88.63	3.38	5.37	0.00	0.00	0.40
thymus, adult, pool1	10027-101D9	67.01	1.09	2.39	0.10	0.20	0.40
thymus, fetal, pool1	10043-101F7	122.82	3.32	4.36	0.42	0.42	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	85.49	4.12	2.39	3.32	0.00	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	59.23	1.54	3.21	1.54	0.00	0.42
thyroid, adult, pool1	10028-101E1	51.60	4.11	4.29	0.00	0.00	0.09
thyroid, fetal, donor1	10060-101H6	40.08	7.91	9.23	0.53	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	86.23	3.08	0.00	9.24	0.00	0.00
tongue, adult	10203-103F5	44.19	1.63	2.56	0.23	0.70	0.93
tongue, fetal, donor1	10059-101H5	28.37	1.58	5.12	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	103.88	2.91	3.11	0.50	5.81	2.60
trachea, adult, pool1	10029-101E2	59.63	2.04	1.80	0.74	0.74	0.33
trachea, fetal, donor1	10058-101H4	37.32	2.69	1.54	0.38	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	34.72	0.35	0.00	2.48	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	84.50	2.33	1.82	2.84	0.00	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	47.95	4.39	1.72	0.47	0.00	0.31
tridermal teratoma cell line:HGRT	10694-109G1	53.27	3.81	3.81	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	45.20	5.76	2.88	0.42	0.00	0.08
umbilical cord, fetal, donor1	10057-101H3	43.82	4.17	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	91.12	7.17	4.27	1.02	2.56	2.22
uterus, fetal, donor1	10055-101H1	41.98	3.58	0.51	0.51	0.00	0.00
vagina, adult	10204-103F6	40.06	0.65	1.29	0.00	0.00	0.00
vein, adult	10191-103E2	69.05	2.41	1.75	0.66	3.29	2.41
xeroderma pigentosum b cell line:XPL 17	10563-108A5	52.87	0.00	0.00	0.00	0.00	0.00